Dexmedetomidine Terminated Phase 1 Trials for Fentanyl (DB00813)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03938857DOSE Trial of Opioid Sparing EffectTreatment